PedersoliGattai
PedersoliGattai maintains a dedicated specialist healthcare and life sciences group. It advises on corporate and regulatory matters that may be contentious or non-contentious. The firm serves clients from the pharmaceutical, biotechnology and medical devices sectors. Luca Saraceni, who is expert in advising a broad spectrum of clients on M&A transactions in the healthcare and life sciences industry, leads the practice alongside Sergio Fienga, who is experienced in administrative and regulatory matters.
Legal 500 Editorial commentary
Key clients
- Vista Vision
- Affidea
- Advanced Sterilization Products Italia
- Astidental Bquadro
- Epilate
- Hollycon Italy
- NTP Nano Tech Projects
- NMS Group
- Fondazione EBRI (European Brain Research Institute)
Work highlights
- Assisting the shareholders of Plurima in the agreement between Poste Italiane and Opus, owned by the Marconi family, and private equity firm Siparex for the acquisition of a majority stake in Plurima, a leading Italian logistics company for the medical sector.
- Assisted EXOR in the acquisition of a co-controlling interest in Lifenet, a company active in the healthcare sector in the management of hospitals and outpatient clinics, through the purchase of a shareholding from the majority shareholder, Invin, and the subscription of a capital increase of Lifenet, reserved for subscription to EXOR.
- Assisted Astidental Bquadro, an Italian company specialising in the distribution of equipment and items for dentists, dental laboratories and dental clinics, in the sale of the majority stake in the company to Gioconda, the Italian branch of LBO France, through Small Caps Opportunities II fund.
Practice head
The lawyer(s) leading their teams.
Luca Saraceni, Sergio Fienga